| Primary |
| Hiv Infection |
38.4% |
| Product Used For Unknown Indication |
15.4% |
| Drug Use For Unknown Indication |
14.7% |
| Drug Exposure During Pregnancy |
13.0% |
| Maternal Exposure Timing Unspecified |
4.6% |
| Antiretroviral Therapy |
4.2% |
| Acquired Immunodeficiency Syndrome |
1.1% |
| Hypertension |
0.9% |
| Hiv Test Positive |
0.9% |
| Antifungal Prophylaxis |
0.9% |
| Maternal Exposure During Pregnancy |
0.9% |
| Systemic Antiviral Treatment |
0.8% |
| Antiviral Treatment |
0.7% |
| Insomnia |
0.6% |
| Diffuse Panbronchiolitis |
0.6% |
| Hepatitis C |
0.5% |
| Prophylaxis |
0.5% |
| Factor Viii Deficiency |
0.4% |
| Mycobacterium Avium Complex Infection |
0.4% |
| Gastritis |
0.4% |
|
| Abortion Spontaneous |
14.6% |
| Drug Exposure During Pregnancy |
12.3% |
| Vomiting |
9.0% |
| Premature Baby |
7.9% |
| Foetal Exposure During Pregnancy |
6.7% |
| Weight Decreased |
4.6% |
| Abortion Induced |
3.9% |
| Umbilical Cord Abnormality |
3.9% |
| Nausea |
3.8% |
| Stillbirth |
3.6% |
| Weight Increased |
3.6% |
| Renal Failure |
3.3% |
| Lymphoma |
3.0% |
| Meningitis Cryptococcal |
3.0% |
| Thrombocytopenia |
3.0% |
| Viral Load Increased |
3.0% |
| Renal Failure Acute |
2.8% |
| Trisomy 21 |
2.8% |
| Diarrhoea |
2.6% |
| Maternal Exposure During Pregnancy |
2.6% |
|
| Secondary |
| Hiv Infection |
67.1% |
| Product Used For Unknown Indication |
6.0% |
| Drug Use For Unknown Indication |
5.4% |
| Antiretroviral Therapy |
4.6% |
| Acquired Immunodeficiency Syndrome |
3.3% |
| Antiviral Treatment |
2.4% |
| Drug Exposure During Pregnancy |
2.1% |
| Hypertension |
1.2% |
| Hiv Test Positive |
1.0% |
| Hepatitis C |
1.0% |
| Prophylaxis |
0.9% |
| Antifungal Prophylaxis |
0.9% |
| Depression |
0.8% |
| Diabetes Mellitus |
0.5% |
| Factor Viii Deficiency |
0.5% |
| Insomnia |
0.5% |
| Opportunistic Infection Prophylaxis |
0.5% |
| Tuberculosis |
0.4% |
| Trigeminal Neuralgia |
0.4% |
| Maternal Exposure Timing Unspecified |
0.3% |
|
| Pregnancy |
9.7% |
| Vomiting |
9.3% |
| Renal Failure Acute |
9.1% |
| Drug Exposure During Pregnancy |
7.4% |
| Myocardial Infarction |
6.6% |
| Premature Baby |
5.8% |
| Renal Colic |
5.8% |
| Thrombocytopenia |
4.3% |
| Osteonecrosis |
4.1% |
| Umbilical Cord Abnormality |
3.9% |
| Renal Impairment |
3.8% |
| Rash |
3.7% |
| Maternal Exposure During Pregnancy |
3.5% |
| Renal Failure |
3.5% |
| Stillbirth |
3.5% |
| Abortion Spontaneous |
3.4% |
| Weight Decreased |
3.4% |
| Weight Increased |
3.3% |
| Diabetes Mellitus |
3.0% |
| Gastrointestinal Malformation |
3.0% |
|
| Concomitant |
| Hiv Infection |
67.1% |
| Product Used For Unknown Indication |
7.3% |
| Drug Use For Unknown Indication |
4.5% |
| Hepatitis C |
3.6% |
| Acquired Immunodeficiency Syndrome |
3.5% |
| Depression |
1.6% |
| Prophylaxis |
1.5% |
| Hypertension |
1.5% |
| Hiv Test Positive |
1.4% |
| Antiretroviral Therapy |
1.2% |
| Drug Exposure During Pregnancy |
1.2% |
| Pain |
1.0% |
| Insomnia |
0.8% |
| Antifungal Prophylaxis |
0.7% |
| Anxiety |
0.7% |
| Mycobacterium Avium Complex Infection |
0.6% |
| Hyperlipidaemia |
0.6% |
| Diabetes Mellitus |
0.5% |
| Factor Viii Deficiency |
0.4% |
| Nausea |
0.4% |
|
| Vomiting |
9.2% |
| Abortion Spontaneous |
8.1% |
| Rash |
6.9% |
| Renal Failure Acute |
6.6% |
| Pyrexia |
6.1% |
| Weight Decreased |
5.6% |
| Renal Failure |
5.3% |
| Myocardial Infarction |
5.1% |
| Death |
4.9% |
| Anaemia |
4.8% |
| Thrombocytopenia |
4.8% |
| Nephrolithiasis |
4.7% |
| Pregnancy |
4.5% |
| White Blood Cell Count Decreased |
4.2% |
| Renal Colic |
3.8% |
| Weight Increased |
3.8% |
| Renal Tubular Disorder |
3.2% |
| Premature Baby |
3.1% |
| Renal Impairment |
2.7% |
| Stillbirth |
2.6% |
|
| Interacting |
| Hiv Infection |
48.9% |
| Product Used For Unknown Indication |
12.4% |
| Infection |
10.4% |
| Drug Use For Unknown Indication |
8.6% |
| Hiv Test Positive |
2.9% |
| Antiretroviral Therapy |
2.4% |
| Acute Myocardial Infarction |
2.0% |
| Chemotherapy |
1.6% |
| Herpes Simplex |
1.5% |
| Maternal Exposure Timing Unspecified |
1.5% |
| Depression |
1.1% |
| Epilepsy |
1.0% |
| Squamous Cell Carcinoma |
1.0% |
| Retroviral Infection |
0.8% |
| Blood Pressure Increased |
0.7% |
| Crohn's Disease |
0.7% |
| Hiv Test |
0.7% |
| Hypertension |
0.7% |
| Psychotic Disorder |
0.7% |
| Schizoaffective Disorder |
0.7% |
|
| Drug Interaction |
28.1% |
| Renal Failure Chronic |
10.1% |
| Vomiting |
5.6% |
| Oedema Peripheral |
4.5% |
| Overdose |
4.5% |
| Rash |
4.5% |
| Renal Failure |
4.5% |
| Renal Failure Acute |
4.5% |
| Skin Exfoliation |
4.5% |
| Visual Acuity Reduced |
4.5% |
| Neuropathy Peripheral |
3.4% |
| Pancytopenia |
3.4% |
| Unevaluable Event |
3.4% |
| Abnormal Weight Gain |
2.2% |
| Cushing's Syndrome |
2.2% |
| Foetal Exposure During Pregnancy |
2.2% |
| Hepatic Enzyme Increased |
2.2% |
| Torsade De Pointes |
2.2% |
| Weight Increased |
2.2% |
| Adverse Event |
1.1% |
|